drugset / Trial / NCT01277640

Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures

NCT01277640

Phase 1 Completed 48 enrolled International Partnership for Microbicides, Inc.
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine the safety of male genitalia when exposed to dapivirine gel following seven once daily applications.

Timeline

Start
2011-03
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator dapivirine Small molecule 2.5 g Topical

Indications

No indication recorded.